Last reviewed · How we verify
Saline solution 0.9% of sodium chloride
Saline solution 0.9% of sodium chloride is a Small molecule drug developed by Biomedica Foscama S.p.A. Industria Chimico-Farmaceutica. It is currently in Phase 3 development for Treatment of dehydration, hypovolemia, and shock.
Saline solution 0.9% of sodium chloride acts as an isotonic solution to restore fluid balance and electrolyte levels.
Saline solution 0.9% of sodium chloride acts as an isotonic solution to restore fluid balance and electrolyte levels. Used for Treatment of dehydration, hypovolemia, and shock.
At a glance
| Generic name | Saline solution 0.9% of sodium chloride |
|---|---|
| Sponsor | Biomedica Foscama S.p.A. Industria Chimico-Farmaceutica |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
It works by replenishing fluids and electrolytes in the body, helping to maintain proper hydration and prevent dehydration. This is particularly useful in medical settings where patients may be at risk of fluid loss due to surgery, illness, or other factors.
Approved indications
- Treatment of dehydration, hypovolemia, and shock
Common side effects
- Hypersensitivity reactions
- Infection
- Allergic reactions
Key clinical trials
- Effect of Lidocaine Infusion Versus Dexmedemidine Infusion on the Neurocognitive Function of Elderly Patients Undergoing Endoscopic Retrograde Cholangiopancreatography(ERCP): a Randomized, Controlled Trial. (NA)
- PRP Injection Into the Sacroiliac Joint After Ipsilateral THA: Effects on Early Recovery and Function (SIJ-THA Randomized Trial) (NA)
- Pulse Glucocorticoid Therapy in Patients With ST-Segment Elevation Myocardial Infarction (PHASE2)
- Magnesium Supplementation in Advanced Non-small Cell Lung Cancer (NSCLC) (PHASE2, PHASE3)
- Thumb Base Osteoarthritis: Ultrasound-guided Platelet-rich Plasma Versus Placebo Injection (PHASE2)
- Safety Evaluation of PfSPZ Vaccine in Pregnant Women in Mali (MalVIP1) (PHASE1)
- Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies (PHASE1)
- Impact of Sugammadex Versus Neostigmine on Early Postoperative Pulmonary Function (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Saline solution 0.9% of sodium chloride CI brief — competitive landscape report
- Saline solution 0.9% of sodium chloride updates RSS · CI watch RSS
- Biomedica Foscama S.p.A. Industria Chimico-Farmaceutica portfolio CI